Objective: The liver X receptors (LXRs) are ligand-activated nuclear transcription factors that have been shown to play major roles in lipid, glucose and cholesterol metabolism. Recently, members of the NR4A orphan nuclear receptor family have also been shown to regulate the expression of important genes in metabolically active tissues such as liver, adipose and skeletal muscle. Here, we investigated the role of LXRs to regulate the expression of the nuclear receptor NOR-1 (neuron-derived orphan receptor-1) in adipocytes. Approach: White and brown adipose tissues from wild-type, LXRaÀ/À-and LXRa:b-deficient mice were collected from animals at room temperature or following cold exposure to measure NOR-1 mRNA. The expression of NOR-1 and its promoter activity in response to LXR ligands were determined in cultured primary brown adipocytes or mouse embryo fibroblasts derived from wildtype or LXRaÀ/À mice differentiated into adipocytes. Results: In LXRaÀ/À-and LXRa:b-deficient adipocytes, basal levels of NOR-1 were significantly reduced while retaining an equivalent proportional induction by b-adrenergic agonists. This reduced basal expression of NOR-1 in adipose tissue from LXR-deficient mice is a cell-autonomous event as it was also preserved in adipocytes differentiated from mouse embryo fibroblasts derived from these mice. In cultured primary brown adipocytes or cell lines, the expression of NOR-1 increased in response to an LXR agonist. A DNA sequence element (DR-4) capable of binding LXRs was found at À997 bp of the NOR-1 promoter, which was shown to be functional by promoter reporter gene activity, gel shift and chromatin immunoprecipitation assays. Conclusion: These data describe a new role for LXR to regulate NOR-1 gene expression in adipocytes and demonstrate that these two nuclear receptors have an interdependent regulatory relationship, in addition to each being involved in the control of metabolic fuel usage.
Introduction
Orphan nuclear receptors are members of the nuclear receptor superfamily of transcription factors for which ligands are currently either unknown or do not exist. 1 The
NR4As are one such family, consisting of three members (Nur77, Nurr1 and neuron-derived orphan receptor-1 (NOR-1)). They were originally identified as a group of closely related proteins the transcription of which is regulated by a wide array of signals ranging from growth factors and hormones to apoptotic and inflammatory stimuli, depending upon the cell type. [2] [3] [4] [5] [6] More recently, these receptors have been shown to function in the regulation of important genes involved in metabolic homeostasis in the liver, adipose and muscle. [7] [8] [9] [10] From structural considerations, the NR4As do not appear to contain a functional ligand-binding pocket, and thus are ligand-independent transcriptional regulators. 11, 12 Of the several stimuli known to increase the expression of the NR4As, many do so through elevations in cyclic adenosine monophosphate (cAMP) levels. 9, 10, 13, 14 Although regulatory motifs for this cAMP-stimulated transcription of the Nur77 and Nurr1 genes are still unclear, at least for NOR-1, a series of three cAMP response element motifs have been identified in its promoter. 15 Another former orphan nuclear receptor family for which ligands are now known is the LXRs: LXRa and LXRb. They are important regulators of lipid, glucose Both LXRa and LXRb increase target gene transcription by binding to DNA sequence motifs composed of two hexameric nucleotide direct repeats separated by four bases (DR-4). 19 Although in the earlier study, LXRa and NOR-1 were separately shown to participate in regulating genes involved in metabolic fuel usage, [7] [8] [9] [10] 16, 20 our current studies in adipocytes identify a direct involvement of LXRa to regulate NOR-1 gene transcription through a DR-4 element in the NOR-1 promoter.
Materials and methods

Animal experiments
The generation of LXRaÀ/À and LXRa:bÀ/À mice was described earlier. 21 Cell culture and transfections HIB-1B brown pre-adipocytes were maintained in Dulbecco's modified essential medium with 10% fetal bovine serum. Upon reaching confluency, they were differentiated into adipocytes by the addition of rosiglitazone (1 mM) for 5 days. Primary brown adipocytes were prepared from brown adipose tissue as described earlier. 22 Cells were differentiated into adipocytes in the presence of 50 nM insulin, 50 nM thyroid hormone (T3) and 1 mM rosiglitazone for 10 days. Mouse embryo fibroblasts from wild-type (WT) and LXRaÀ/À mouse embryos were cultured as described earlier. 20 They were differentiated into adipocytes by the addition of dexamethasone (20 mg ml À1 ), IBMX (110 mg ml
À1
), rosiglitazone (2.5 mM) and insulin (10 mg ml À1 ) for the first 2 days followed by 6-8 days in the same media without dexamethasone as described earlier. 20 Where in- and pGL3-NOR1-2XDR4 (1.0 mg), mLXRa (0.5 mg), pCMV5-hRXRa (0.5 mg) and b-galactosidase (0.2 mg). Six hours after transfection, the peroxisome proliferator-activated receptor-g agonist rosiglitazone (1 mM) was added to the cells, followed 18 h later by 1 mM T09 for 6 h in Dulbecco's modified essential medium supplemented with 10% dextran-coated charcoalstripped serum. Cells were collected for luciferase (Promega) and b-galactosidase (Promega) assays as described earlier.
9,20
RNA isolation and analysis Total cellular RNA was extracted from tissues or cultured cells using TRI Reagent (Sigma). High Capacity cDNA Archive kit from Applied Biosystems (Foster City, CA, USA) was used to generated cDNA, and reverse transcription PCR (RT-PCR) was performed on an ABI PRISM 7700 Sequence Detector (Perkin Elmer, Shelton, CT, USA) using Taqman probes or SYBRGreen reagent and specific primers (Integrated DNA Technologies, Huntsville, AL, USA) as indicated for specific experiments. Expression levels for all genes were normalized to the mean value of the internal control glyceraldehyde 3-phosphate dehydrogenase, which did not fluctuate in response to drug treatments within individual experiments.
Electrophoretic mobility shift assay Nuclear extracts were prepared (TransFactor; BD Biosciences, Palo Alto, CA, USA), and double-stranded gel shift probes were end labeled with [g-32 P]-ATP and T4 polynucleotide kinase. The binding reactions (10 ml) contained 5 mg of nuclear protein in a buffer composed of 25 mM HEPES Adipocyte LXR and NOR-1 gene expression N Kumar et al (pH 7.9), 0.5 mM EDTA, 0.5 mM dithiothreitol, 1% Nonidet P-40, 5% glycerol, 50 mM NaCl and 1 mg poly (dÉ -dC). Unlabeled competitor oligonucleotides were added to the binding reaction mixtures in molar excess (detailed in figure legends) immediately before the addition of labeled oligonucleotides. Reaction mixtures were incubated at room temperature for 15 min, DNA-protein complexes were resolved on a 6% DNA-retardation gel for 40 min at 180 V and gels were then dried and subjected to autoradiography on phosphor screens (Amersham, Piscataway, NJ, USA).
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation assays were performed using a commercial kit (Upstate, Temecula, CA, USA) according to the manufacturer's protocol. Briefly, differentiated HIB-1B cells were treated with T09 (1 mM) for 4 h. For the cross-linking step, formaldehyde (37%, V/V) was added directly to the culture medium to achieve a final concentration of 1% and incubated for 10 min at 37 1C. Cells were rinsed twice with cold PBS, harvested and then lysed in 0.4 ml of SDS buffer (1% SDS, 10 mM EDTA, 50 mM Tris, pH 8.1). The lysates were sonicated at 30% power using a Sonifier cell disruptor 350 and centrifuged at 16 000 g for 10 min. The supernatants were diluted 10-fold with a buffer (24 ml of 0.01% SDS, 1.1% Triton X-100, 
Results
Recently, we showed that the expression of NOR-1 in differentiated brown and white adipocytes is robustly and transiently increased by b-adrenergic-stimulated increases in cAMP levels. One of the functions of NOR-1 in this setting is to augment the cAMP-dependent transcription of the Ucp1 gene. 9 As in other cell types, the stimulation of NOR-1 expression in adipocytes occurs through cAMP response elements in the NOR-1 promoter 15 (see Figure 1) . However, even under basal conditions, the expression of NOR-1 in adipocytes is readily detected. In addition to the cAMP response elements, a closer examination of the NOR-1
promoter revealed a potential DR-4 element between À997 and À982 bp (Figure 1 ). Of the candidate nuclear receptors that can bind to this element, LXRs are present in adipocytes and serve important roles in lipid metabolism. Considering the relatively high lipid flux in adipocytes, we first measured NOR-1 gene expression in brown adipose tissue and white adipose tissue obtained from WT and LXR-deficient mice.
The results showed that in brown adipose tissue ( Figure 2a ) and white adipose tissue (Figure 2b ), NOR-1 expression was significantly reduced in LXRaÀ/À and LXRa:bÀ/À mice as compared with WT mice. A more modest reduction in the expression of Nur77 and Nurr1 was also observed in LXRaÀ/À and LXRa:bÀ/À mice as compared with WT mice (data not shown). When the animals were challenged with cold exposure, which increases sympathetic nervous system catecholamine release in adipose tissue to activate b-adrenoceptors, NOR-1 expression was significantly lower in mice lacking either LXRa or both LXR isoforms than in WT mice. However, when assessed relative to the respective basal levels of expression, the net fold increase was similar. To begin to explore the possibility that LXR might be a direct regulator of the NOR-1 gene through the potential DR-4 element we found, we began a series of in vitro experiments using adipocyte cell models. First, mouse embryo fibroblasts derived from wild-type or LXRaÀ/À mice were subject to a standard adipocyte differentiation protocol and the expression of NOR-1 was examined. Cells from both genotypes could differentiate into adipocytes as shown earlier. 20 Similar to the decreased expression observed in adipose tissues from mice, basal NOR-1 transcript levels were significantly reduced in adipocytes differentiated from LXRaÀ/À cells compared with WT cells (Figure 3 ; see inset). Also shown in Figure 3 is that in response to the b-adrenergic agonist Iso, the overall increase in NOR-1 expression was significantly lower in LXRaÀ/À adipocytes relative to wild-type cells. However, again when expressed as the net fold change above the basal level, the response to Iso was similar between genotypes. These results indicate the possibility that LXRa 
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CRE-3 CRE-1 CRE-2 Figure 1 Location of a candidate DR-4 sequence as an LXR-binding site in the NOR-1 promoter. Three closely spaced CREs in the proximal promoter between À79 and À46 bp from the start site of transcription (raised arrow) were described earlier 15 and are shown in capital letters. A motif scan of sequence extending 2 kb upstream of the transcription start site from the Ensembl database indicated a potential DR-4 element between À997 and À982 bp. CRE, cAMP response element.
Adipocyte LXR and NOR-1 gene expression N Kumar et al might regulate basal NOR-1 expression. In a second model, we used primary cultures of differentiated murine brown fat cells. They were treated with the synthetic LXRa agonist T09 (1 mM) for 6 h and NOR-1 gene expression was measured. Figure 4a shows that T09 increased NOR-1 gene expression by approximately sixfold. Finally, similar results were obtained in the immortalized HIB-1B brown adipocyte cell line (Figure 4b ). However, we did not observe any significant increase in the expression of Nur77 and Nurr1 in either cell model in response to an LXR agonist (data not shown).
To determine whether the candidate DR-4 sequence at À997 bp in the NOR-1 promoter was an LXRa-binding site, we performed electromobility shift assays with an oligonucleotide containing this potential binding site, as shown in Figure 5a . The results presented below the sequences show that binding (lane 1) was progressively lost in the presence of increasing amounts (10 Â and 100 Â ) of unlabeled probe (Figure 5b, lanes 2 and 3) , whereas a similar challenge with a mutated DR-4 sequence was only weakly able to compete for binding (lanes 4 and 5). These in vitro findings were extended to chromatin immunoprecipitation assays. HIB-1B brown adipocytes were treated or not with T09 (1 mM) for 4h. As shown in Figure 5b , LXRa was recovered from the NOR-1 promoter under basal conditions and its binding was significantly enhanced (2.4-fold) in response to the LXR agonist. Little to no recovery occurred from samples with anti-IgG antibody, demonstrating the specificity of the interaction.
On the basis of these physical interaction measurements, the next experiments were designed to determine whether Adipocyte LXR and NOR-1 gene expression N Kumar et al this DR-4 sequence is directly involved in the activation of NOR-1 gene expression by LXRa. A basic minimal promoter driving luciferase (pluc-MCS) expression was constructed to contain two tandem DR-4 elements. These two plasmids were transfected into HIB-1B cells and their ability to increase luciferase activity in response to T09 was assessed.
As shown in Figure 5c , the activity in response to T09 of the construct containing the DR4 sequences was significantly higher than that of basic pluc-MCS plasmid. This result indicates that the sequence from À997 to À982 from the NOR-1 promoter can function in isolation as an LXR response element. Figure 5d shows the comparison of the parental pGL3 plasmid vs pGL3 containing the proximal portion of the NOR-1 promoter with or without the 2XDR4. In response to the LXR agonist, there was some activity of the NOR-1 promoter itself for reasons that are unclear. However, the activity of pGL3-NOR-1-2XDR4 was significantly greater, indicating that the presence of the DR4 motif was also functional. These results, taken together, show that LXRa regulates basal expression of the NOR-1 gene in adipose tissue, and we have identified the promoter element to which it binds.
Discussion
At one time, the 'orphan' nuclear receptors outnumbered the known hormone-regulated members of the nuclear receptor superfamily. 23 Over the past 10 years as ligands for many of these receptors have been discovered, including the oxysterols for the LXRs, the remaining members of this 'orphan' class have come to be recognized as a special group the regulation of which is largely driven by their rapid and transient expression in response to intracellular signals. 24 For example, Ruis et al. 15 identified a set of three cAMP response elements in the NOR-1 promoter that increases gene transcription in response to cAMP levels. The NR4As are also subject to regulatory modifications including phosphorylation. 25 The NR4A family (NOR-1, Nur77 and Nurr1) has been reported to be involved in growth control and developmental processes in several different cell types. 2, 3, 6 More recently, they have been implicated in the control of metabolic energy homeostasis in the liver, adipose and muscle. NR4A receptors were shown to contribute to the cAMP-dependent transcription of glucose-6-phosphatase in the liver, a key step in hepatic gluconeogenesis, 10 as well as to the regulation of genes involved in glucose and oxidative metabolism in skeletal muscle. 8, 26 In adipose tissue, NR4As have been linked to the recruitment of GLUT4 receptors to the plasma membrane, resulting in improved insulin sensitivity, 7 and in brown adipocytes, NOR-1 contributes to the cAMP-dependent transcription of the Ucp1 gene, the induction of which is necessary for sustained adaptive thermogenesis. 9 Our finding of another transcriptional regulatory pathway to regulate NR4As, and the NOR-1 gene in particular in response to LXR, underscores the fact that we still do not know the full extent to which there is cross-talk between the nuclear receptor families to modulate each other's expression. We have focused on adipose tissue in these studies, but given the robust amounts of LXRa in the liver and spleen, it will be instructive to examine whether NR4A family members may also be regulated by LXRs in those tissues to better understand the physiology of these interesting ligandindependent nuclear receptors. Adipocyte LXR and NOR-1 gene expression N Kumar et al
